Showing results (41-50 of 248) with videos related to

Sort By:
Pageof 25
Bioorganic & Medicinal Chemistry|May 24, 2005
Fancy bioisosteres: synthesis, SAR, and pharmacological investigations of novel nonaromatic dopamine D3 receptor ligandsCarola Lenz, Frank Boeckler, Harald Hübner, et al.
Synapse (New York, N.Y.)|June 2, 2006
Dopamine D2 and D3 receptors in human putamen, caudate nucleus, and globus pallidusPhilip Seeman, Alan Wilson, Peter Gmeiner, et al.
Bioorganic & Medicinal Chemistry|September 6, 2017
β-Arrestin biased dopamine D2 receptor partial agonists: Synthesis and pharmacological evaluationBarbara Männel, Harald Hübner, Dorothée Möller, et al.
Plos One|July 5, 2013
Active-state models of ternary GPCR complexes: determinants of selective receptor-G-protein couplingRalf C Kling, Harald Lanig, Timothy Clark, et al.
Bioorganic & Medicinal Chemistry|September 11, 2007
Click chemistry based solid phase supported synthesis of dopaminergic phenylacetylenesPilar Rodriguez Loaiza, Stefan Löber, Harald Hübner, et al.
Bioorganic & Medicinal Chemistry|July 14, 2009
Parallel synthesis of potent dopaminergic N-phenyltriazole carboxamides applying a novel click chemistry based phenol linkerPilar Rodriguez Loaiza, Stefan Löber, Harald Hübner, et al.
Bioorganic & Medicinal Chemistry Letters|January 29, 2011
Aromatic ring functionalization of benzolactam derivatives: new potent dopamine D3 receptor ligandsRaquel Ortega, Harald Hübner, Peter Gmeiner, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 27, 2011
The bulky N6 substituent of cabergoline is responsible for agonism of this drug at 5-hydroxytryptamine 5-HT2A and 5-HT2B receptors and thus is a determinant of valvular heart diseaseAlexandra Kekewska, Harald Hübner, Peter Gmeiner, et al.
Bioorganic & Medicinal Chemistry|February 2, 2015
GPCR crystal structures: Medicinal chemistry in the pocketJeremy Shonberg, Ralf C Kling, Peter Gmeiner, et al.
Pageof 25